(Q40467785)

20 September 2017

title

Clinical experiences using everolimus-eluting stents in patients with coronary artery disease. (English)

1 reference

20 September 2017

Hans Störger

1

1 reference

20 September 2017

Eberhard Grube

2

1 reference

20 September 2017

Manfred Hofmann

3

1 reference

20 September 2017

Franz Schwarz

4

1 reference

20 September 2017

Jürgen Haase

5

1 reference

20 September 2017

publication date

1 December 2004

1 reference

Journal of Interventional Cardiology

20 September 2017

published in

1 reference

20 September 2017

volume

17

1 reference

20 September 2017

issue

6

1 reference

20 September 2017

page(s)

387-390

1 reference

A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2004.04080.X

Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary Artery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2004.04080.X

Sirolimus-eluting stent for treatment of complex in-stent restenosis: the first clinical experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2004.04080.X

The role of Certican (everolimus, rad) in the many pathways of chronic rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2004.04080.X

SDZ RAD, a new rapamycin derivative: pharmacological properties in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2004.04080.X

Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2004.04080.X

10.1111/J.1540-8183.2004.04080.X

21 January 2018

Identifiers

DOI

1 reference

20 September 2017

1 reference